Alvotech (ALVO) Stock Forecast, Price Target & Predictions
ALVO Stock Forecast
Alvotech stock forecast is as follows: an average price target of $16.00 (represents a 27.39% upside from ALVO’s last price of $12.56) and a rating consensus of 'Hold', based on 3 wall street analysts offering a 1-year stock forecast.
ALVO Price Target
The average price target for Alvotech (ALVO) is $16.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $22.00 to $10.00. This represents a potential 27.39% upside from ALVO's last price of $12.56.
ALVO Analyst Ratings
According to 3 Wall Street analysts, Alvotech's rating consensus is 'Hold'. The analyst rating breakdown for ALVO stock is 0 'Strong Buy' (0.00%), 1 'Buy' (33.33%), 2 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Alvotech Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 24, 2024 | Balaji Prasad | Barclays | $22.00 | $13.58 | 62.00% | 75.16% |
| May 21, 2024 | Balaji Prasad | Barclays | $20.00 | $13.76 | 45.35% | 59.24% |
| Jan 29, 2024 | Balaji Prasad | Barclays | $17.00 | $15.25 | 11.48% | 35.35% |
| Jul 01, 2022 | Emmanuel Papadakis | Deutsche Bank | $10.00 | $8.21 | 21.80% | -20.38% |
The latest Alvotech stock forecast, released on May 24, 2024 by Balaji Prasad from Barclays, set a price target of $22.00, which represents a 62.00% increase from the stock price at the time of the forecast ($13.58), and a 75.16% increase from ALVO last price ($12.56).
Alvotech Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 3 |
| Avg Price Target | - | - | $19.67 |
| Last Closing Price | $12.56 | $12.56 | $12.56 |
| Upside/Downside | -100.00% | -100.00% | 56.61% |
In the current month, the average price target of Alvotech stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Alvotech's last price of $12.56. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 21, 2024 | Barclays | Overweight | Overweight | Hold |
| Jan 29, 2024 | Barclays | Overweight | Upgrade | |
| Oct 20, 2023 | Citigroup | Neutral | Upgrade | |
| Jul 01, 2022 | Deutsche Bank | Hold | Initialise |
Alvotech's last stock rating was published by Barclays on May 21, 2024. The company gave ALVO a "Overweight" rating, the same as its previous rate.
Alvotech Financial Forecast
Alvotech Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Jun 23 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $333.94M | $306.27M | $280.90M | $257.63M | $87.50M | $85.00M | $198.75M | $93.00M | $42.00M |
| High Forecast | $359.65M | $329.85M | $302.52M | $277.46M | $98.69M | $91.54M | $214.05M | $100.16M | $45.23M |
| Low Forecast | $308.23M | $282.70M | $259.28M | $237.79M | $76.31M | $78.46M | $183.45M | $85.84M | $38.77M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - |
Alvotech's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. ALVO's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Alvotech EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Jun 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $-259.90M | $-238.37M | $-218.62M | $-200.51M | $-68.10M | $-66.15M | $-154.69M | $-72.38M | $-32.69M |
| High Forecast | $-239.89M | $-220.02M | $-201.79M | $-185.07M | $-59.39M | $-61.06M | $-142.78M | $-66.81M | $-30.17M |
| Low Forecast | $-279.91M | $-256.72M | $-235.45M | $-215.94M | $-76.81M | $-71.25M | $-166.59M | $-77.95M | $-35.20M |
| Surprise % | - | - | - | - | - | - | - | - | - |
undefined analysts predict ALVO's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Alvotech's previous annual EBITDA (undefined) of $NaN.
Alvotech Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Jun 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $18.11M | $23.28M | $2.59M | $5.17M | $2.59M | $-16.30M | $776.02K | $10.86M | $-36.21M |
| High Forecast | $19.92M | $25.61M | $2.85M | $5.69M | $2.85M | $-14.67M | $853.68K | $11.95M | $-32.59M |
| Low Forecast | $16.30M | $20.95M | $2.33M | $4.66M | $2.33M | $-17.93M | $698.36K | $9.78M | $-39.84M |
| Surprise % | - | - | - | - | - | - | - | - | - |
Alvotech's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ALVO's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Alvotech SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Jun 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $519.64M | $476.59M | $437.10M | $400.89M | $136.16M | $132.27M | $309.28M | $144.72M | $65.36M |
| High Forecast | $559.64M | $513.27M | $470.75M | $431.75M | $153.56M | $142.45M | $333.08M | $155.86M | $70.39M |
| Low Forecast | $479.64M | $439.90M | $403.45M | $370.03M | $118.75M | $122.08M | $285.47M | $133.58M | $60.32M |
| Surprise % | - | - | - | - | - | - | - | - | - |
Alvotech's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to ALVO last annual SG&A of $NaN (undefined).
Alvotech EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Jun 23 | |
|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $0.07 | $0.09 | $0.01 | $0.02 | $0.01 | $-0.06 | - | $0.04 | $-0.14 |
| High Forecast | $0.08 | $0.10 | $0.01 | $0.02 | $0.01 | $-0.06 | - | $0.05 | $-0.13 |
| Low Forecast | $0.06 | $0.08 | $0.01 | $0.02 | $0.01 | $-0.07 | - | $0.04 | $-0.15 |
| Surprise % | - | - | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, Alvotech's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ALVO previous annual EPS of $NaN (undefined).
Alvotech Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ASRT | Assertio | $0.88 | $3.00 | 240.91% | Buy |
| AMPH | Amphastar Pharmaceuticals | $38.27 | $66.00 | 72.46% | Buy |
| CYTH | Cyclo Therapeutics | $0.60 | $0.95 | 58.33% | Buy |
| ANIP | ANI Pharmaceuticals | $54.16 | $79.00 | 45.86% | Buy |
| COLL | Collegium Pharmaceutical | $29.06 | $42.33 | 45.66% | Buy |
| ALVO | Alvotech | $12.56 | $16.00 | 27.39% | Hold |
| ALKS | Alkermes | $29.65 | $37.50 | 26.48% | Hold |
| PCRX | Pacira BioSciences | $19.47 | $23.75 | 21.98% | Hold |
| ITCI | Intra-Cellular Therapies | $85.24 | $94.25 | 10.57% | Buy |
| CTLT | Catalent | $63.48 | $63.50 | 0.03% | Hold |
| LFCR | Lifecore Biomedical | $7.60 | $6.50 | -14.47% | Buy |